Michael Kamarck
Director/Board Member bei VAXCYTE, INC.
Vermögen: 384 244 $ am 31.03.2024
Profil
Derzeit bekleidet Michael E. Kamarck die Position des Chief Technology Officer bei Vir Biotechnology, Inc. Dr. Kamarck ist außerdem Mitglied des Vorstands von Trillium Therapeutics, Inc. und Unilife Medical Solutions, Inc. sowie Mitglied von TransForm Pharmaceuticals, Inc. In der Vergangenheit war er SVP-Global Vaccines & Biologics Manufacturing bei Merck & Co., Inc. und Präsident von Merck BioVentures (einer Tochtergesellschaft von Merck & Co., Inc.), Head-Therapeutic Monoclonal Antibodies bei Sanofi, President-Technical Operations & Product Supply bei Wyeth Pharmaceuticals, Inc. und Principal bei Willow Creek Biotech Consulting LLC. Er erwarb einen Bachelor-Abschluss am Oberlin College und einen Doktortitel am Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
VAXCYTE, INC.
0,01% | 13.06.2023 | 5 625 ( 0,01% ) | 384 244 $ | 31.03.2024 |
PASSAGE BIO, INC.
-.--% | 25.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Michael Kamarck
Unternehmen | Position | Beginn |
---|---|---|
VAXCYTE, INC. | Director/Board Member | 27.10.2021 |
PASSAGE BIO, INC. | Director/Board Member | 02.07.2022 |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Kamarck
Unternehmen | Position | Ende |
---|---|---|
TRILLIUM THERAPEUTICS | Director/Board Member | 17.11.2021 |
UNILIFE CORP | Director/Board Member | 26.10.2017 |
Willow Creek Biotech Consulting LLC | Corporate Officer/Principal | 01.05.2017 |
OMNI BIO PHARMACEUTICAL, INC. | Director/Board Member | 24.06.2015 |
SANOFI | Corporate Officer/Principal | 01.12.2014 |
Ausbildung von Michael Kamarck
Oberlin College | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
MERCK & CO., INC. | Health Technology |
SANOFI | Health Technology |
VAXCYTE, INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
PASSAGE BIO, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Trillium Therapeutics ULC
Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Unilife Corp.
Unilife Corp. Medical SpecialtiesHealth Technology Unilife Corp. designs, develops, manufactures and supplies injectable drug delivery systems. The company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its devices to enable or enhance the clinical development, regulatory approval and lifecycle management of injectable therapies. The company was founded by Alan D. Shortall in 2001 and is headquartered in York, PA. | Health Technology |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
Unilife Medical Solutions, Inc.
Unilife Medical Solutions, Inc. Electronic Equipment/InstrumentsElectronic Technology Unilife Medical Solutions, Inc. operates as a medical device contract manufacturer of disposable devices. It engages in the design, development, and validation of automated equipment used in the production of medical devices. The firm’s project management services include product design and support and prototyping, molding, assembly, printing, packaging, sterilization, and quality control. The company is headquartered in York, PA. | Electronic Technology |
Omni Bio Pharmaceutical, Inc.
Omni Bio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company, which engages in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naurally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO. | Health Technology |
Merck BioVentures | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
Willow Creek Biotech Consulting LLC |